| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 71 |
| 1 | ADALIMUMAB | 58 |
| 2 | BORTEZOMIB | 57 |
| 3 | METHOTREXATE | 56 |
| 4 | DEXAMETHASONE | 55 |
| 5 | DEXAMETHASONE 1.5 MG | 55 |
| 6 | PREDNISONE | 52 |
| 7 | FUROSEMIDE | 49 |
| 8 | LENALIDOMIDE | 43 |
| 9 | RITUXIMAB | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CITRATE DIHYDRATE | 1 | 0.0244 |
| 1 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE | 1 | 0.0065 |
| 2 | SORBITOL | 3 | 0.0050 |
| 3 | ESOMEPRAZOLE SODIUM | 10 | 0.0041 |
| 4 | AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE | 1 | 0.0039 |
| 5 | BORON | 1 | 0.0033 |
| 6 | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | 1 | 0.0023 |
| 7 | MOMETASONE FUROATE MONOHYDRATE | 1 | 0.0020 |
| 8 | RITUXIMAB-ABBS | 9 | 0.0018 |
| 9 | ESTRADIOL CYPIONATE | 1 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 139 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 74 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 68 |
| 3 | Proteasome Inhibitor [EPC] | 59 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 57 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 56 |
| 6 | Loop Diuretic [EPC] | 56 |
| 7 | Benzodiazepine [EPC] | 50 |
| 8 | Thalidomide Analog [EPC] | 47 |
| 9 | Factor Xa Inhibitor [EPC] | 40 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 30 | 0.0051 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Provitamin D2 Compound [EPC] | 35 | 0.0012 |
| 3 | Human C1 Esterase Inhibitor [EPC] | 3 | 0.0008 |
| 4 | Human Immunoglobulin G [EPC] | 16 | 0.0008 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 3 | 0.0006 |
| 6 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 7 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 8 | Proteasome Inhibitor [EPC] | 59 | 0.0005 |
| 9 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |